Nestle Waters North America Inc. — Jimmy Buffett’s Island Tea
by Nestle Waters North America Inc.MRT 176 Panel Triggers Identified
Clinical Product Assessment
Nestle Waters North America Inc. manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 6 MRT-tested substances, including four fruit/sugar triggers and two chemical/additive triggers. It also contains ‘natural flavors’ and ‘modified food starch’, which are potential hidden sources of additional reactive substances. Due to the high trigger count, this product is categorized as High Risk and is only suitable for the maintenance phase under clinical supervision.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 6
- Safe Ingredients: 3
- Unknown/Ambiguous: 2 (natural flavors, modified food starch)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| sugar | Cane Sugar | Direct Match |
| apple juice concentrate | Apple | Direct Match |
| pear juice concentrate | Pear | Direct Match |
| orange juice concentrate | Orange | Direct Match |
| citric acid | Citric Acid | Chemical Match |
| black tea extract | Tea | Direct Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel: natural flavors, modified food starch. Patients should treat these as potential triggers until MRT testing confirms safety.
LEAP Protocol Guidance
With 6 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist.
UPC Code: 088130910239
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Cane sugar sensitivity is specific to sugarcane-derived sweeteners and is distinct from glucose intolerance. Look for it in ingredient lists as sucrose, cane juice, or turbinado sugar.
Apple is an MRT-tested fruit that appears in juice blends, baby food, applesauce, pectin-based products, and as a sweetener (apple juice concentrate) in many "natural" foods.
Orange is an MRT-tested citrus fruit. Found in juice, marmalade, candied peel, and as natural orange flavoring. Cross-reactivity with other citrus fruits is not assumed on the MRT panel.
A chemical additive tested on the MRT panel. Industrially produced from Aspergillus niger mold, not citrus fruit. Found in beverages, canned goods, candy, and as a preservative in thousands of products.
Tea (Camellia sinensis) is MRT-tested. Covers black, green, white, and oolong teas. Distinct from caffeine sensitivity — you may react to tea proteins but not caffeine, or vice versa.
What This Means For Your Diet
With 6 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 6 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from Nestle Waters North America Inc.
About This Assessment
This safety assessment was generated by cross-referencing the USDA FoodData Central ingredient record for this product against the 176 substances tested on the Mediator Release Test (MRT) panel. Clinical notes are produced with AI assistance using the matched ingredient data and reviewed by Kerry Watson, NTP, RWP for accuracy against published LEAP ImmunoCalm® protocol guidelines. Risk classifications are based on the number and type of MRT-tested substances identified. This information is for educational purposes only and is not medical advice — always consult your Certified LEAP Therapist before making dietary changes.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners